loader
Please Wait
Applying Filters...
menu
    • menu

    Drug Product Composition: Elvitegravir

    Client Email Product
    Menu

    Elvitegravir

    ACTIVE PHARMA INGREDIENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    SearchXls

    USFDA APPLICATION NUMBER - 203093 / DOSAGE - TABLET;ORAL - 85MG

    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    ELVITEGRAVIR(UNII: 4GDQ854U53)
    (ELVITEGRAVIR - UNII:4GDQ854U53)     		ELVITEGRAVIR150mg | 85mg

    Inactive Ingredients

    Ingredient Name
    Gilead Sciences, Inc.
    CELLULOSE, MICROCRYSTALLINE(OP1R32D61U)
    CROSCARMELLOSE SODIUM(M28OL1HH48)
    FD&C BLUE NO. 2(L06K8R7DQK)
    FERRIC OXIDE YELLOW(EX438O2MRT)
    HYDROXYPROPYL CELLULOSE (TYPE H)(RFW2ET671P)
    LACTOSE MONOHYDRATE(EWQ57Q8I5X)
    MAGNESIUM STEARATE(70097M6I30)
    POLYETHYLENE GLYCOL 3350(G2M7P15E5P)
    POLYVINYL ALCOHOL(532B59J990)
    SODIUM LAURYL SULFATE(368GB5141J)
    TALC(7SEV7J4R1U)
    TITANIUM DIOXIDE(15FIX9V2JP)
    WATER(059QF0KO0R)